Treatment strategies in nonalcoholic fatty liver disease
Explore this paper's citation graph
Summary
It is recommended that patients at high risk of developing advanced liver disease, and who are not part of controlled studies, should receive nutritional counseling and take physical exercise to achieve moderate weight loss and improve insulin sensitivity.
- Type
- article
- Published
- 2005-03-01
- Cited by
- 67
- References
- 56
- OpenAlex
- https://openalex.org/W16265156
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:1012256
Keywords
Political science
References
- Clinical Hepatic Impairment after the Duodenal Switch
- Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
- Nonalcoholic fatty liver disease.
- Regression of hepatic steatosis in morbidly obese persons after gastric bypass.
- Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women
- Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease
- Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
- Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review.
- Molecular mediators of hepatic steatosis and liver injury.
- The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
- The utility of radiological imaging in nonalcoholic fatty liver disease.
- Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
- Beneficial Effects of Tumor Necrosis Factor-α Inhibition by Pentoxifylline on Clinical, Biochemical, and Metabolic Parameters of Patients with Nonalcoholic Steatohepatitis
- Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease
- Effect of weight control on hepatic abnormalities in obese patients with fatty liver.
- Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity.
- Angiotensin‐II type 1 receptor interaction is a major regulator for liver fibrosis development in rats
- Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
- Hepatic effects of dietary weight loss in morbidly obese subjects.
- A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis
Cited by
- Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non‐alcoholic fatty liver disease
- Clinical-Pathological Conference Series from the Medical University of Graz
- Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease.
- Classificação da esteatose hepática usando imagens ecográficas
- Anti-diabetic Effect and Mechanism of Korean Red Ginseng in C57BL/KsJ db/db Mice
- Diet prescription for non‐alcoholic fatty liver disease: Is it worth the effort? A systematic review
- Prevention and treatment of nonalcoholic fatty liver disease.
- Bifidobacterium adolescentis protects from the development of nonalcoholic steatohepatitis in a mouse model.
- High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease
- The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans.
- Interrelaciones entre obesidad y aterotrombosis
- Causes and metabolic consequences of Fatty liver.
- Metformin therapy: Benefits beyond glycemic control
- Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis
- Environmental and Genetic Determinants of Fatty Liver in Humans
- 'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis.
- Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity
- Fat luck: three siblings requiring liver transplantation for nonalcoholic steatohepatitis
- Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.
- [Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle].
Related papers
No related papers recorded.